Tissue factor exposing microparticles in inflammatory bowel disease

Journal of Crohn's and Colitis

Volumn 7, Issue 3, 2013, Pages 222-229

  Palkovits, Julia ^a   Novacek, Gottfried ^a   Kollars, Marietta ^a   Hron, Gregor ^a   Osterode, Wolf ^a   Quehenberger, Peter ^a   Kyrle, Paul Alexander ^a,b   Vogelsang, Harald ^a   Reinisch, Walter ^a   Papay, Pavol ^a   Weltermann, Ansgar ^a,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Karl Landsteiner Institute of Thrombosis Research   (Austria)

^c ELISABETHINEN HOSPITAL   (Austria)

Author keywords

Inflammatory bowel disease; Microparticles; Platelets; Tissue factor; Venous thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; C REACTIVE PROTEIN; CORTICOSTEROID; D DIMER; INFLIXIMAB; PROCOAGULANT; THROMBOPLASTIN; TISSUE FACTOR MICROPARTICLE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASSAY; BLOOD CLOTTING; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL DISEASE ACTIVITY INDEX; CONTROLLED STUDY; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; ENTERITIS; FEMALE; FLOW CYTOMETRY; HUMAN; INFLAMMATION; LEUKOCYTE; MALE; PLASMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOCYTE; ULCERATIVE COLITIS;

ADULT; BIOLOGICAL MARKERS; BLOOD COAGULATION; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FLOW CYTOMETRY; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; THROMBOPLASTIN;

EID: 84873732842     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.05.016     Document Type: Article

References (46)

1. Talbot R.W., Heppell J., Dozois R.R., Beart R.W., et al. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1988, 61:140-145.
2. Grip O., Svensson P., Lindgren S. Inflammatory bowel disease promotes venous thrombosis earlier in life. Scand J Gastroenterol 2000, 35:619-623.
3. Bernstein C.N., Blanchard J.F., Houston D.S., Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 2001, 85:430-434.
4. Solem C.A., Loftus E.V., Tremaine W.J., Sandborn W.J. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol 2004, 99:97-101.
5. Miehsler W., Reinisch W., Valic E., Osterode W., Tillinger W., Feichtenschlager T., et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?. Gut 2004, 53:542-548.
6. Nguyen G.C., Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 2008, 103:1-9.
7. Grainge M.J., West J., Card T.R. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 2010, 375(9715):657-663.
8. Novacek G., Weltermann A., Sobala A., Tilg H., Petrisch W., Reinisch W., et al. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism. Gastroenterology 2010, 139:779-787.
9. Kappelman M.D., Horvath-Puho E., Sandler R.S., Rubin D.T., Ullman T.A., Pederson L., et al. Thromboembolic risk among Danish children and adults with inflammatroy bowel disease: a population-based nationwide study. Gut 2011, 60:937-943.
10. Danese S., Papa A., Saibeni S., Repici A., Malesci A., Vecchi M. Inflammation and coagulation in inflammatory bowel disease: the clot thickens. Am J Gastroenterol 2007, 102:174-186.
11. Vrij A.A., Rijken J., van Wersch J.W., Stockenbrügger R.W. Coagulation an fibrinolysis in inflammatory bowel disease and giant cell arteritis. Pathophysiol Haemost Thromb 2003, 33:75-83.
12. Alkim H., Ayaz S., Alkim C., Ulker A., Sahin B. Continuous active state of coagulation system in patients with nonthrombotic inflammatory bowel disease. Clin Appl Thromb Hemost 2011, 17:600-604.
13. Cybulsky M., Chan W., Movat H. Acute inflammation and microthombosis induced by endotoxin, interleukin-1 and tumor necrosis factor and their implication in gram-negative infection. Lab Invest 1988, 58:365-378.
14. Dosquet C., Weill D., Wautier J.L. Cytokines and thrombosis. J Cardiovasc Pharmacol 1995, 25(Suppl. 2):S13-S19.
15. Opal S.M., Esmon C.T. Bench-to-bedside review: functional relationship between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit Care 2003, 7:23-38.
16. Poredos P., Jezovnik M.K. The role of inflammation in venous thromboembolism and the link between arterial and venous thrombosis. Int Angiol 2007, 26:306-311.
17. Hommes D.W., van Dullemen H.M., Levi M., van der Ende A., Woody J., Tygat G.N., et al. Beneficial effect of treatment with a monoclonal anti-tumor necrosis factor-alpha antibody on markers of coagulation and fibrinolysis in patients with active Crohn's disease. Haemostasis 1997, 27:269-277.
18. Charmouard P., Desprez D., Hugel B., Kunzelmann C., Gidon-Jeangirard C., Lessard M., et al. Circulating cell-derived microparticles in Crohn's disease. Dig Dis Sci 2005, 50:574-580.
19. Andoh A., Tsujikawa T., Hata K., Araki Y., Kitoh K., Sasaki M., et al. Elevated circulating platelet derived microparticles in patients with active inflammatory bowel disease. Am J Gastroenterol 2005, 100:2042-2048.
20. Pamuk G.E., Vural O., Turgut B., Demir M., Umit H., Tezel A. Increased circulating platelet-neutrophil, platelet-monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study. Am J Hematol 2006, 81:753-759.
21. Freyssinet J.M. Cellular microparticles: what are they bad or good for?. J Thromb Haemost 2003, 1:1655-1662.
22. Miyazaki Y., Nomura S., Miyake T., Kagawa H., Kitada C., Taniguchi H., et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 1996, 88:3456-3464.
23. Siljander P., Carpen O., Lassila R. Platelet-derived microparticles associate with fibrin during thrombosis. Blood 1996, 87:4651-4663.
24. Rauch U., Nemerson Y. Circulating tissue factor and thrombosis. Curr Opin Hematol 2000, 7:273-277.
25. Tesselaar M.E., Romijn F.P., van der Linden I.K., Prins F.A., Bertina R.M., Osanta S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis?. J Thromb Haemost 2007, 5:520-527.
26. Zwicker J.I., Liebman H.A., Neuberg D., Lacroix R., Bauer K.A., Furie B.C., et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res 2009, 15:6830-6840.
27. Tsimerman G., Roguin A., Bachar A., Melamed E., Brenner B., Aharon A. Involvement of microparticles in diabetic vascular complications. Thromb Haemost 2011, 106:310-321.
28. Van Assche G., Dignass A., Panes J., Beaugerie L., Karagiannis J., Alez M., et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis 2010, 4:7-27.
29. Stange E.F., Travis S.P.L., Vermeire S., Reinisch W., Geboes K., Barakauskiene A., et al. European evidence based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohns Colitis 2008, 2:1-23.
30. Best W.R., Becktel J.M., Singelton J.W., Kern F. Development of a Crohn's disease activity index: National Cooperative Crohn's Disease Study. Gastroenterology 1976, 70:439-444.
31. Rachmilewitz D. Coated mesalazine (5-aminosalicyclic acid) versus sulpha-salazine in the treatment of active ulcerative colitis: a randomized trial. BMJ 1989, 298:82-86.
32. Rutgeerts P. Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphalazine for maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 1989, 3:183-191. International Study Group.
33. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19(Suppl. A):5-36.
34. Hron G., Kollars M., Weber H., Sagaster V., Quehenberger P., Eichinger S., et al. Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost 2007, 97:119-123.
35. Collins C.E., Rampton D.S., Rogers J., Williams N.S. Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1997, 9:1213-1217.
36. Danese S., Katz J., Saibeni S., Papa A., Gasbarrini A., Vecchi M., et al. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut 2003, 52:1435-1441.
37. Heijnen H.F., Schiel A.E., Fijnheer R., Geuze H.J., Sixma J.J. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 1999, 94:3791-3799.
38. Rauch U., Bonderman D., Bohrmann B., Badimon J.J., Himber J., Riederer M.A., et al. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 2000, 96:170-175.
39. Danese S., de La Motte C., Sturm A., Vogel J.D., West G.A., Strong S.A., et al. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology 2003, 124:1249-1264.
40. Collins C., Cahill M., Newland A., Rampton D.S. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 1994, 106:840-845.
41. Slupsky J.R., Kalbas M., Willuweit A., henn V., Kroczek R.A., Müller-Berghaus G. Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40. Thromb Haemost 1998, 80:1008-1014.
42. Lindmark E., Tenno T., Siegbahn A. Role of platelets P-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arterioscler Thromb Vasc Biol 2000, 20:2322-2328.
43. van Bodegraven A.A., Schoorl M., Linskens R.K. Persistent activation of coagulation and fibrinolysis after treatment of active ulcerative colitis. Eur J Gastroenterol Hepatol 2002, 14:413-418.
44. Holme P.A., Solum N.O., Brosstad F., Pederson T., Kveine M. Microvesicles bind soluble fibrinogen, adhere to immobilized fibrinogen and coaggregate with platelets. Thromb Haemost 1998, 79:389-394.
45. Gray E., Thomas S., Mistry Y., Poole S. Inhibition of tissue factor and cytokine release. Haemostasis 1996, 26:92-95.
46. Poitevin S., Cochery-Noevellon E., Dupont A., Nguyen P. Monocyte IL-10 produced in response to lipopolysaccaride modulates thrombin generation by inhibiting tissue factor expression and release of active tissue factor-bound microparticles. Thromb Haemost 2007, 97:598-607.